These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2909522)

  • 1. Location of the antithrombin-binding sequence in the heparin chain.
    Oscarsson LG; Pejler G; Lindahl U
    J Biol Chem; 1989 Jan; 264(1):296-304. PubMed ID: 2909522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.
    Kusche M; Bäckström G; Riesenfeld J; Petitou M; Choay J; Lindahl U
    J Biol Chem; 1988 Oct; 263(30):15474-84. PubMed ID: 3139669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of heparin. Enzymatic sulfation of pentasaccharides.
    Kusche M; Oscarsson LG; Reynertson R; Rodén L; Lindahl U
    J Biol Chem; 1991 Apr; 266(12):7400-9. PubMed ID: 1902219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
    Pejler G; Danielsson A; Björk I; Lindahl U; Nader HB; Dietrich CP
    J Biol Chem; 1987 Aug; 262(24):11413-21. PubMed ID: 3624220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites.
    Kusche M; Torri G; Casu B; Lindahl U
    J Biol Chem; 1990 May; 265(13):7292-300. PubMed ID: 2332430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of periodate-oxidized heparin.
    Conrad HE; Guo Y
    Adv Exp Med Biol; 1992; 313():31-6. PubMed ID: 1332442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.
    Lindahl U; Bäckström G; Thunberg L; Leder IG
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6551-5. PubMed ID: 6935668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension and structural variability of the antithrombin-binding sequence in heparin.
    Lindahl U; Thunberg L; Bäckström G; Riesenfeld J; Nordling K; Björk I
    J Biol Chem; 1984 Oct; 259(20):12368-76. PubMed ID: 6490618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N; Lindahl U
    J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.
    Petitou M; Casu B; Lindahl U
    Biochimie; 2003; 85(1-2):83-9. PubMed ID: 12765778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the antithrombin-binding sequence in heparin.
    Thunberg L; Bäckström G; Lindahl U
    Carbohydr Res; 1982 Mar; 100():393-410. PubMed ID: 7083257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.
    Kusche M; Hannesson HH; Lindahl U
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):151-8. PubMed ID: 1902083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of critical groups required for the binding of heparin to antithrombin.
    Atha DH; Stephens AW; Rosenberg RD
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1030-4. PubMed ID: 6583694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
    Arocas V; Turk B; Bock SC; Olson ST; Björk I
    Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
    Danielsson A; Raub E; Lindahl U; Björk I
    J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts.
    Hricovíni M; Guerrini M; Bisio A
    Eur J Biochem; 1999 May; 261(3):789-801. PubMed ID: 10215897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
    Atha DH; Stephens AW; Rimon A; Rosenberg RD
    Biochemistry; 1984 Nov; 23(24):5801-12. PubMed ID: 6525337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.